{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:26:07Z","timestamp":1748107567306},"reference-count":59,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2020,7,2]]},"DOI":"10.1080\/14728214.2020.1787984","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:36:43Z","timestamp":1594816603000},"page":"201-211","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Emerging drugs for the treatment of hidradenitis suppurativa"],"prefix":"10.1080","volume":"25","author":[{"given":"Alecia S","family":"Folkes","sequence":"first","affiliation":[{"name":"Dermatology, Larkin Community Hospital, South Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris Z","family":"Hawatmeh","sequence":"additional","affiliation":[{"name":"Dermatology, Nova Southeastern University, Fort Lauderdale-Davie, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Wong","sequence":"additional","affiliation":[{"name":"Dermatology, Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A","family":"Kerdel","sequence":"additional","affiliation":[{"name":"Dermatology, Florida Academic Dermatology Center, Coral Gables, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10034.x"},{"issue":"13","key":"cit0002","first-page":"53","volume":"13","author":"Lim SYD","year":"2019","journal-title":"Biologics"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.005"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00087.x"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.162"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.06.020"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13777"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.173"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.07.055"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1159\/000503605"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1159\/000453355"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2334"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90321-7"},{"issue":"4","key":"cit0014","first-page":"438","volume":"148","author":"Rambhatla PV","year":"2012","journal-title":"Arch Dermatol"},{"key":"cit0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/ijdvl.IJDVL_69_18","volume":"85","author":"Tchero H","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.050"},{"issue":"2","key":"cit0017","first-page":"170","volume":"18","author":"Kerdel FR","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.046"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.010"},{"issue":"12","key":"cit0020","first-page":"1170","volume":"99","author":"Hotz C","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"cit0021","volume-title":"U.S. Food and Drug Administration. Step 3: clinical Research [Internet]","year":"2018"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.07.010"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14075"},{"issue":"2","key":"cit0024","doi-asserted-by":"crossref","first-page":"AB155","DOI":"10.1016\/j.jaad.2010.01.030","volume":"64","author":"Kimball a","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12104"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.06.031"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.027"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1540"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05663.x"},{"key":"cit0030","volume-title":"Identifier NCT03852472, evaluation of safety and efficacy of avacopan in subjects with moderate to severe hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179"},{"key":"cit0032","volume-title":"Identifier NCT03512275, a study of bermekimab in patients with hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.10.024"},{"key":"cit0034","volume-title":"Identifier NCT03827798, study of efficacy and safety of investigational treatments in patients with moderate to severe hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15661"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz013"},{"key":"cit0037","volume-title":"Identifier NCT03607487, a placebo-controlled study of the safety of INCB054707 in participants with hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0038","volume-title":"Identifier NCT03569371, a study of the safety of INCB054707 in participants with hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2008-6"},{"key":"cit0040","author":"Page KM","year":"2020","journal-title":"J Invest Dermatol"},{"key":"cit0041","volume-title":"Identifier NCT04092452, a study to evaluate the safety and efficacy of PF-06650833, PF-06700841, and PF 06826647 in adults with hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1185-9"},{"key":"cit0043","volume-title":"Identifier NCT03099980, exploratory trial evaluating cosentyx (Secukinumab) for patients with moderate-to-severe hidradenitis","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0044","volume-title":"Identifier NCT03713619, This is a study of efficacy and safety of two secukinumab dose regimens in subjects with moderate to severe hidradenitis suppurativa (HS)","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0045","volume-title":"Identifier NCT03713632, study of efficacy and safety of two secukinumab dose regimens in subjects with moderate to severe hidradenitis suppurativa (HS)","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15015"},{"key":"cit0048","first-page":"60","volume":"9","author":"Fala L","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15370"},{"key":"cit0050","first-page":"9679287","volume":"2018","author":"Ehrlich D","year":"2018","journal-title":"Case Rep Gastrointest Med"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.12.002"},{"key":"cit0052","volume-title":"Identifier NCT04242446, a study to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (BE HEARD I)","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0053","volume-title":"Identifier NCT04242498, a study to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (BE HEARD II)","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"key":"cit0054","volume-title":"Identifier NCT03248531, a study to test the efficacy, safety and pharmacokinetics of bimekizumab in subjects with moderate to severe hidradenitis suppurativa","author":"ClinicalTrials.gov [Internet]","year":"2000"},{"issue":"7","key":"cit0055","volume":"23","author":"Yao Y","year":"2017","journal-title":"Dermatol Online J"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"issue":"15","key":"cit0057","first-page":"87","volume":"19","author":"Quartuccio L","year":"2018","journal-title":"J Adv Res"},{"issue":"10","key":"cit0058","first-page":"354","volume":"110","author":"Raaflaub J","year":"1980","journal-title":"Schweiz Med Wochenschr"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07067.x"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2020.1787984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T06:47:16Z","timestamp":1620456436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2020.1787984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7,2]]}},"alternative-id":["10.1080\/14728214.2020.1787984"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2020.1787984","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}